posted on 2022-11-30, 11:13authored byWafaa Al-Gburi
<p>Hypertension and vascular remodelling play central roles in the pathophysiology of heart disease, stroke, peripheral atherosclerosis, and renal failure. Gαs-coupled G protein-coupled receptor (GPCR) activation [e.g. β2-adrenoceptor (β<sub>2</sub>AR), adenosine A2B receptor (A<sub>2B</sub>R)] causes vascular smooth muscle cell (VSMC) relaxation, counteracting effects of vasoconstrictors. G protein-coupled receptor kinases (GRK) and arrestins regulate GPCR signalling, and dysregulated Gαs/GPCR signalling is key in the development of hypertension, probably via increased GRK2/arrestin VSMC expression. Evidence indicates β<sub>2</sub>AR and A<sub>2B</sub>R are GRK/arrestin substrates, however similar potential interactions have not been fully investigated in VSMC.</p>
<p>β<sub>2</sub>AR and A<sub>2B</sub>R signalling promotes cAMP production, activating multiple downstream signalling pathways, including CREB, mediating vaso-relaxatory effects of Gαs-coupled GPCRs. Characterisation of β<sub>2</sub>AR-induced CREB signalling revealed PKA is essential for the early stages, and EPAC the later stages of β<sub>2</sub>AR-mediated CREB-phosphorylation, implying that cAMP-driven processes are required to produce β<sub>2</sub>AR-stimulated CREB-signalling. A2BR-induced CREB signalling relied on p38/Src-kinase, and not cAMP/PKA/EPAC. GRK2 siRNA-targeted knockdown/or chemical inhibition, blocked β<sub>2</sub>AR-stimulated CREB-phosphorylation. Similar data were obtained following arrestin2 depletion. A2BR-stimulated CREB-phosphorylation required GRK5/arrestin3 expression. β<sub>2</sub>AR-stimulated p38 signals were PKA/EPCA independent, but required GRK2/arrestin2 expression. A2BR-induced p38 signalling was GRK5-dependent, but arrestin/PKA /EPAC-independent.</p>
<p>VSMC migration is central to hypertension-induced vascular remodelling, and here β<sub>2</sub>AR and A<sub>2B</sub>R-stimulated Gαs/GPCR signalling blocks VSMC migration through cAMP-dependent signalling pathways including CREB. CREB, GRK2 or GRK5 inhibition attenuated vasoconstrictor-stimulated VSMC migration, but failed to affect the ability of β<sub>2</sub>AR and A<sub>2B</sub>R signalling to prevent vasoconstrictor-stimulated VSMC migration. Activation EPAC was equally as effective as β<sub>2</sub>AR and A<sub>2B</sub>R agonists at blocking vasoconstrictor-stimulated VSMC migration.</p>
<p>This research indicates that β<sub>2</sub>AR and A<sub>2B</sub>R activate CREB and p38 signalling in RASM, and these signalling pathways are selectively regulated by GRK and arrestin proteins. β<sub>2</sub>AR and A<sub>2B</sub>R activity prevents vasoconstrictor-promoted VSMC migration, however, it is unclear whether this blockade relies on agonist-stimulated CREB and/or p38 activation.</p>